IQV Stock Analysis: Buy, Sell, or Hold?
IQV - IQVIA Holdings Inc.
$230.15
-5.47 (-2.32%)
▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 05, 2026
4d
Get Alerted When IQV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: IQV shows positive signals but monitor for confirmation. Market pricing in 0.9% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: IQV shows positive signals but monitor for confirmation. Market pricing in 0.9% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$312.15
Based on 6.4% avg growth
INTRINSIC VALUE TODAY
$193.82
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IQV is currently trading at $230.15, which is considered slightly high relative to its 30-day fair value range of $228.42 to $242.35. The stock's valuation (Forward PE: 18.2) is in line with its historical norms (17.7). At these levels, the market is pricing in 0.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, IQV is in a strong uptrend. The price is currently testing key support at $227.99. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $261.15 (+10.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IQV is in a strong uptrend. The price is currently testing key support at $227.99. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $261.15 (+10.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$228.42 -
$242.35
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.8%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($261.15)
- NEUTRAL: Market pricing in 0.9% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$228.42 -
$242.35
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$227.99
Resistance Level
$244.16
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
18.21
Wall Street Target
$261.15
(+10.8%)
Revenue Growth (YoY)
5.2%
Earnings Growth (YoY)
24.5%
Profit Margin
8.1%
Valuation Premium vs History
+0.9% premium
PE vs Historical
18.2 vs 17.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.9%
(market-implied from PE analysis)
1-Year Target
$237.74
(+1%)
2-Year Target
$239.88
(+2%)
3-Year Target
$242.04
(+3%)
3-Yr Target (if PE normalizes)
(PE: 18→18)
PE COMPRESSION
$235.29
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 8.8%)
$371.74
(+58%)
Base:
(SPY PE: 18.2, Growth: 8.8%)
$303.52
(+29%)
Bear:
(PE: 15.5, Growth: 8.8%)
$257.99
(+10%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (33x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 32.93 | Current EPS (TTM): $7.28
Bull Case
$468.81
(+104%)
Analyst growth 77.8%, PE expands to 36.2
Base Case
$426.19
(+85%)
Market implied 77.8%, PE stable at 32.9
Bear Case
$163.04
(-29%)
Severe decline -20.0%, PE contracts to 28.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 31, 2026 12:12 AM ET
Data refreshes hourly during market hours. Next update: 1:12 AM
Data refreshes hourly during market hours. Next update: 1:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IQV showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
NEUTRAL
Recent Transactions
Ro Khanna
BUY
2025-09-29
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 47 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$121 | 62 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$263 | 47 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 58 HOLD |
Advanced IQV Option Strategies
Professional options setups generated by AI based on today's IQV price and gamma walls.
